Home / Tolterodine / Ireland
IE ATC G04BD07 · updated 2 Nov 2026
Tolterodine shortage in Ireland
Is there a Tolterodine shortage in Ireland?
Yes. As of 2 Nov 2026, 7 Tolterodine products are reported short in Ireland, the first since 8 Jan 2025. The company estimate for the return is 16 Nov 2026 (latest 23 Nov 2026). Main reason: increased demand.
Also short in Canada, Germany, Spain, Austria, Belgium, Norway, Sweden. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Tendrotil SR 4 mg Prolonged-Release Capsules, Hard | Accord Healthcare Ireland Ltd. | 8 Jan 2025 | not given | Quality problem or recall Quality issue |
| IE | Trusitev SR 2 mg Prolonged-release Capsules, hard | Teva Pharma B.V. | 11 Jan 2025 | not given | Distribution or logistics Shipping delay/distribution issue |
| IE | Tendrotil SR 2 mg Prolonged-Release Capsules, Hard | Accord Healthcare Ireland Ltd. | 5 Feb 2025 | not given | Quality problem or recall Quality issue |
| IE | Trusitev SR 4 mg Prolonged-release Capsules, hard | Teva Pharma B.V. | 19 Feb 2025 | not given | Manufacturing problem Manufacturing delay |
| IE | Detrusitol 1 mg film-coated tablets | Viatris Healthcare Limited | 17 Aug 2026 | 16 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Detrusitol SR 4 mg prolonged-release capsules, hard | Viatris Healthcare Limited | 12 Oct 2026 | 23 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Toltertan SR 4 mg Prolonged-Release Capsules, Hard | Clonmel Healthcare Ltd | 30 Oct 2026 | not given | Increased demand Unexpected increased demand |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.